Literature DB >> 24167706

Treatment of clozapine-induced priapism by goserline acetate injection.

Gursharan Lal Kashyap1, Jitendra Nayar, Adnan Bashier, Soosamma Varghese.   

Abstract

Clozapine (Denzapine) is a treatment for resistant schizophrenia. Among the serious but rare side effects of clozapine are agranulocytosis and priapism. We hereby present the case of a 30-year-old man with a diagnosis of schizophrenia who has spent nearly 12 years of his adult life on various psychiatric in-patient units including open wards, secure units, psychiatric intensive care units and rehab wards. Diagnosed at the age of 15, he only responded to clozapine at the age of 18. Whilst being on clozapine he developed priapism in June 2010 and needed emergency surgical treatment in the form of surgical decompression. He again responded only to clozapine and fortunately he did not redevelop priapism; however, he was readmitted in February 2011 due to relapse, and he remained resistant to other antipsychotics. He was rechallenged with clozapine and recovered, but unfortunately redeveloped priapism which required emergency surgical and medical intervention (goserline acetate and tinzaperin injection). In order to relieve the recurrent priapism, he agreed to continue clozapine and goserline acetate injection. This decision was made by the patient in a compos mentis state. As far as we are aware, this is the first time goserline acetate has been reported as a successful treatment for clozapine-induced priapism.

Entities:  

Keywords:  Denzapine; clozapine; goserline acetate injection; priapism; resistant schizophrenia

Year:  2013        PMID: 24167706      PMCID: PMC3805388          DOI: 10.1177/2045125313488132

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  11 in total

1.  Olanzapine-induced priapism.

Authors:  D A Songer; J C Barclay
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

Review 2.  The aetiology, pathogenesis and management of priapism.

Authors:  S R Keoghane; M E Sullivan; M A W Miller
Journal:  BJU Int       Date:  2002-07       Impact factor: 5.588

3.  Olanzapine-induced reversible priaprism: a case report.

Authors:  J M Deirmenjian; S M Erhart; D A Wirshing; B J Spellberg; W C Wirshing
Journal:  J Clin Psychopharmacol       Date:  1998-08       Impact factor: 3.153

4.  Clozapine-associated priapism: a case report.

Authors:  A D Seftel; I Saenz de Tejada; B Szetela; J Cole; I Goldstein
Journal:  J Urol       Date:  1992-01       Impact factor: 7.450

5.  [Adverse effects: priapism caused by paroxetine].

Authors:  F Bertholon; Y Krajewski; A el Allali
Journal:  Ann Med Psychol (Paris)       Date:  1996-05       Impact factor: 0.380

6.  Citalopram-associated clitoral priapism: a case series.

Authors:  M Berk; M Acton
Journal:  Int Clin Psychopharmacol       Date:  1997-03       Impact factor: 1.659

Review 7.  Does testosterone have a role in erectile function?

Authors:  Nasser Mikhail
Journal:  Am J Med       Date:  2006-05       Impact factor: 4.965

8.  Priapism: a urological emergency.

Authors:  R Reif; K Výborný
Journal:  Acta Univ Palacki Olomuc Fac Med       Date:  1993

Review 9.  Priapism associated with atypical antipsychotic medications: a review.

Authors:  Shabnam Sood; William James; Maria-Jesus Bailon
Journal:  Int Clin Psychopharmacol       Date:  2008-01       Impact factor: 1.659

Review 10.  [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies].

Authors:  Shigeru Tsukagoshi
Journal:  Gan To Kagaku Ryoho       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.